Skip to main content
Hari Nathan, MD, General Surgery, Ann Arbor, MI, University of Michigan Medical Center

HariNathanMDPhD, FACS, FSSO

General Surgery • Ann Arbor, MI

Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)

Associate Professor and Chief, Division of Hepatopancreatobiliary Surgery, at University of Michigan

Join to view full profile

Dr. Nathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nathan's full profile

Already have an account?

Summary

  • Dr. Hari Nathan is an Associate Professor of Surgery and Chief of the Division of Hepato-Pancreato-Biliary Surgery at the University of Michigan. Dr. Nathan completed both his undergraduate and medical education with honors at The Johns Hopkins University. He was awarded a PhD in Clinical Investigation from The Johns Hopkins Bloomberg School of Public Health. He completed his general surgery residency at The Johns Hopkins Hospital and a clinical fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center, where he also served as the Chief Administrative Fellow in Surgery. He joined the faculty of the University of Michigan in 2014.
    Dr. Nathan’s clinical focus is on tumors of the liver, bile duct, pancreas, and stomach. He has particular interests in the treatment of liver metastases from colorectal cancer and directs Michigan Medicine’s Hepatic Artery Infusion Pump (HAIP) Program. He also serves as the Surgical Director of the Multidisciplinary Pancreatic Cancer Clinic.
    Dr. Nathan’s research seeks to identify strategies to improve outcomes and control costs for surgical care. His work has been funded by the Agency for Healthcare Research and Quality and the National Institute on Aging. He has done substantial work on the quality of cancer surgery and prediction of prognosis after cancer resection. More recently, his research has focused on variation in surgical quality and costs within hospital networks. He was awarded the 2018 American College of Surgeons Joan L. and Julius H. Jacobson II Promising Investigator Award.
    Dr. Nathan is heavily involved in regional efforts to improve healthcare value. He is the Director of the Michigan Value Collaborative, a coalition of 87 Michigan hospitals focused on improving healthcare value in Michigan. He is also the Co-Chair of the Cancer Steering Committee for the Michigan Surgical Quality Collaborative (MSQC) and directs MSQC efforts to standardize pancreatectomy care across Michigan.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2012 - 2014
  • The Johns Hopkins University Bloomberg School of Public Health
    The Johns Hopkins University Bloomberg School of Public HealthPhD, Clinical Investigation, 2006 - 2012
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Surgery, 2004 - 2012
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2004

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2014 - 2027
  • NY State Medical License
    NY State Medical License 2012 - 2015
  • MD State Medical License
    MD State Medical License 2006 - 2009
  • American Board of Surgery Surgery
  • American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

  • Association for Academic Surgery Fall Courses Travel Grant 2013
  • Roger Williams Cancer Center New England Sarcoma Symposium Traveling Fellowship 2011
  • Gershon Efron Award for Outstanding Clinical Research Johns Hopkins University Department of Surgery, 2010-2011
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small Bowel Neuroendocrine Tumors  
    Flavio Rocha, Eleftherios Makris, Mary Dillhoff, Hari Nathan, Daniel Abbott, Shishir K Maithel, Mohammad Y Zaidi, Kenneth Cardona, Megan Beems, Kamran Idrees, JAMA
  • Pharmacologic prophylaxis, post-operative INR, and risk of venous thromboembolism after hepatectomy  
    Nathan H, Weiss MJ, Soff GA, Stempel M, DeMatteo RP, Allen PJ, Kingham TP, Fong Y, Jarnagin WR, D'Angelica MI, J Gastrointest Surg, 1/1/2014
  • Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective  
    Mayo SC, Mavros MN, Nathan H, Cosgrove D, Herman JM, Kamel I, Anders RA, Pawlik TM, J Am Coll Surg, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary Care 
    Chapter: Staging of hepatocellular carcinoma 
    Nathan H, Pawlik TMEditors: McMasters KM, Vauthey JN.Springer, New York, NY2010
  • Avoiding Common ICU Errors 
    Chapter: Start a proton pump inhibitor infusion for gastric and duodenal bleeding 
    Nathan HEditors: Marcucci L, Martinez E, Haut E, Slonim A, Suarez J.Lippincott Williams & Wilkins, Philadelphia, PA2006
  • Avoiding Common ICU Errors 
    Chapter: D-dimer levels can rule out but not rule in pulmonary embolism in postoperative patients 
    Nathan HEditors: Marcucci L, Martinez E, Haut E, Slonim A, Suarez J.Lippincott Williams & Wilkins, Philadelphia, PA2006
  • Join now to see all

Abstracts/Posters

  • Hospital surgical volume and cost of cancer surgery in the elderly
    Nathan H, Atoria CL, Bach PB, Elkin EB, 67th Annual Cancer Symposium of the Society of Surgical Oncology, 3/1/2014
  • Pharmacologic prophylaxis, postoperative INR, and risk of venous thromboembolism after hepatectomy
    Nathan H, Weiss MJ, DeMatteo RP, Allen PJ, Kingham TP, Fong Y, Jarnagin WR, D'Angelica MI, 54th Annual Meeting of the Society for Surgery of the Alimentary Tract, 5/1/2013
  • Influence of non-clinical factors on choice of therapy for early hepatocellular carcinoma
    Nathan H, Bridges JF, Choti MA, Segev DL, Wolfgang CL, Edil BH, Hirose K, Cameron AM, Schulick RD, Pawlik TM, 65th Annual Cancer Symposium of the Society of Surgical Oncology, 3/1/2012
  • Join now to see all

Press Mentions

  • Even at Top Hospitals, Low-Income Older Cancer Patients Struggle After Surgery
    Even at Top Hospitals, Low-Income Older Cancer Patients Struggle After SurgeryMarch 8th, 2022
  • Study Data from University of Michigan Provide New Insights into General Surgery (The Affordable Care Act at 10 Years: Evaluating the Evidence and Navigating an Uncertain Future)
    Study Data from University of Michigan Provide New Insights into General Surgery (The Affordable Care Act at 10 Years: Evaluating the Evidence and Navigating an Uncertain Future)July 5th, 2021
  • Preoperative Testing Is Often Unnecessary for Low-Risk Surgeries, Shows Study
    Preoperative Testing Is Often Unnecessary for Low-Risk Surgeries, Shows StudyMay 18th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations

Dr. Hari Nathan, Dr. Hari Nathan, MD, Dr. H Nathan